نتایج جستجو برای: پروبیوتیک abt 10

تعداد نتایج: 1019339  

Journal: :The Journal of pharmacology and experimental therapeutics 2005
Gerard B Fox Timothy A Esbenshade Jia Bao Pan Richard J Radek Kathleen M Krueger Betty B Yao Kaitlin E Browman Michael J Buckley Michael E Ballard Victoria A Komater Holly Miner Min Zhang Ramin Faghih Lynne E Rueter R Scott Bitner Karla U Drescher Jill Wetter Kennan Marsh Martine Lemaire Roger D Porsolt Youssef L Bennani James P Sullivan Marlon D Cowart Michael W Decker Arthur A Hancock

Acute pharmacological blockade of central histamine H3 receptors (H3Rs) enhances arousal/attention in rodents. However, there is little information available for other behavioral domains or for repeated administration using selective compounds. ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile] exemplifies such a selective, nonimidazole H3R antagonist with high aff...

Journal: :Thrombosis research 2014
Armen V Gyulkhandanyan Asuman Mutlu David J Allen John Freedman Valery Leytin

BACKGROUND Depolarization of mitochondrial inner transmembrane potential (ΔΨm) is a key biochemical manifestation of the intrinsic apoptosis pathway in anucleate platelets. Little is known, however, about the relationship between ΔΨm depolarization and downstream morphological manifestations of platelet apoptosis, cell shrinkage and microparticle (MP) formation. OBJECTIVES To elucidate this r...

Journal: :Journal of Alzheimer's disease : JAD 2014
George M Haig Yili Pritchett Andreas Meier Ahmed A Othman Coleen Hall Laura M Gault Robert A Lenz

BACKGROUND ABT-288, a highly selective histamine-3 receptor antagonist, demonstrated efficacy across several preclinical cognitive domains, and safety in healthy subjects and elderly volunteers. OBJECTIVE Evaluate the efficacy and safety of ABT-288 in subjects with mild-to-moderate Alzheimer's dementia. METHODS The study used a randomized, double-blind, placebo- and active-controlled, paral...

Journal: :Cancer research 2011
Jin H Song Karthikeyan Kandasamy Marina Zemskova Ying-Wei Lin Andrew S Kraft

ABT-737, a small molecule cell-permeable Bcl-2 antagonist that acts by mimicking BH3 proteins, induces apoptotic cell death in multiple cancer types. However, when incubated with this agent many solid tumor cell lines do not undergo apoptosis. The current study reveals a novel mechanism whereby ABT-737 when added to apoptosis-resistant cancer cells has profound biologic effects. In PV-10 cells,...

2014
Abid R. Mattoo Jingyu Zhang Luis A. Espinoza

Purpose: High levels of BCL-2 family members in colorectal carcinoma cause resistance to treatment. Inhibition of NANOG or its paralogNANOGP8 reduces the proliferation, stemness, and tumorigenicity of colorectal carcinoma cells. Our hypothesis was that inhibition of NANOG/NANOGP8 enhances the cytotoxic effect of BH3 mimetics targeting BCL-2 family members in colorectal carcinoma cells through r...

Journal: :Hypertension 2002
Diana Z Ye Donna H Wang

To determine the role of endothelin-1 (ET-1) and its receptors in salt-sensitive hypertension induced by sensory nerve degeneration, selective ET(A) antagonist (ABT-627) and ET(B) antagonist (A-192621) were used. Newborn Wistar rats were given vehicle or 50 mg/kg capsaicin subcutaneously on the first and second days of life. After the weaning period, male rats were divided into eight groups, an...

Journal: :Blood 1994
J O Bordin L Bardossy M A Blajchman

We had reported previously (Blood 81:1880, 1993) that allogeneic blood transfusions (ABT) administered before the infusion of tumor cells in both inbred and outbred experimental animals promote tumor growth and that this effect can be ameliorated by leukodepletion. To better reproduce the human situation, we evaluated, in this present study, the effect of ABT in animals with established tumors ...

Journal: :The Journal of infection 2015
Eric Lawitz Greg Sullivan Maribel Rodriguez-Torres Michael Bennett Fred Poordad Mudra Kapoor Prajakta Badri Andrew Campbell Lino Rodrigues Yiran Hu Tami Pilot-Matias Regis A Vilchez

OBJECTIVES To examine the safety and efficacy of ombitasvir and ABT-450 with ritonavir (ABT-450/r) ± ribavirin (RBV) in treatment-naïve, non-cirrhotic adults with chronic HCV genotype 1-3 infection. METHODS Patients in this open-label, exploratory, phase 2, multicenter study received ombitasvir (25 mg QD) and ABT-450/r (200/100 mg QD) ± RBV for 12 weeks. Primary efficacy endpoint was HCV RNA ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Cyrille Touzeau Christelle Dousset Linda Bodet Patricia Gomez-Bougie Stéphanie Bonnaud Anne Moreau Philippe Moreau Catherine Pellat-Deceunynck Martine Amiot Steven Le Gouill

PURPOSE Mantle cell lymphoma (MCL) is considered to be incurable. ABT-737 is a BH3 mimetic that targets Bcl-2, which is overexpressed in MCL and implicated in drug resistance. The present work investigated the antitumor effect of ABT-737. EXPERIMENTAL DESIGN Six MCL cell lines and primary MCL cells (n = 13) were used. Sensitivity to ABT-737 was assessed, and expression levels of Bcl-2 and Mcl...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید